BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
50 results:

  • 1. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.
    Xu AM; Haro M; Walts AE; Hu Y; John J; Karlan BY; Merchant A; Orsulic S
    Sci Adv; 2024 Apr; 10(16):eadk8805. PubMed ID: 38630822
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
    Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
    Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
    Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
    Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
    Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
    [No Abstract]    [Full Text] [Related]  

  • 7. Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer.
    Lu H; Lou H; Wengert G; Paudel R; Patel N; Desai S; Crum B; Linton-Reid K; Chen M; Li D; Ip J; Mauri F; Pinato DJ; Rockall A; Copley SJ; Ghaem-Maghami S; Aboagye EO
    Cell Rep Med; 2023 Jul; 4(7):101092. PubMed ID: 37348499
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies.
    Senturk ZN; Akdag I; Deniz B; Sayi-Yazgan A
    Front Immunol; 2023; 14():1152551. PubMed ID: 37033931
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
    Li YY; Li SJ; Liu MC; Chen Z; Li L; Shen F; Liu QZ; Xu B; Lian ZX
    J Endocrinol Invest; 2023 Nov; 46(11):2247-2256. PubMed ID: 37004696
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tertiary Lymphoid Structures Are Associated with a Favorable prognosis in High-Grade Serous Ovarian cancer Patients.
    Zhang K; Xie X; Zou LH; Guo SQ
    Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with fus to stabilize FOXR2.
    Liang YX; Zhang LL; Yang L
    Mol Cell Biochem; 2023 Apr; 478(4):835-850. PubMed ID: 36107285
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
    Ukita M; Hamanishi J; Yoshitomi H; Yamanoi K; Takamatsu S; Ueda A; Suzuki H; Hosoe Y; Furutake Y; Taki M; Abiko K; Yamaguchi K; Nakai H; Baba T; Matsumura N; Yoshizawa A; Ueno H; Mandai M
    JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35552285
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. fus-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
    Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcome of Surgical Resection and Chemotherapy Versus Chemotherapy Alone for the Treatment of Isolated Primary Adrenal Lymphoma: A Retrospective Cohort Study of 16 Consecutive Patients.
    Illuminati G; Nardi P; Fratini C; Pasqua R; Giordano C; Girolami M; Carboni F
    Anticancer Res; 2021 May; 41(5):2647-2652. PubMed ID: 33952495
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib.
    Fraunhoffer NA; Abuelafia AM; Bigonnet M; Gayet O; Roques J; Telle E; Santofimia-CastaƱo P; Borrello MT; Chuluyan E; Dusetti N; Iovanna J
    Clin Cancer Res; 2020 Oct; 26(20):5506-5519. PubMed ID: 32669378
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Type II enteropathy-associated T cell lymphoma in the duodenum: A rare case report.
    Liu Z; He L; Jiao Y; Wang H; Suo J
    Medicine (Baltimore); 2020 Jun; 99(23):e20050. PubMed ID: 32501967
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Primary Pancreatic lymphoma: a rare clinical entity.
    Dunphy L; Abbas SH; Al Shoek I; Al-Salti W
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31907215
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Transcriptionally Distinct CXCL13
    Workel HH; Lubbers JM; Arnold R; Prins TM; van der Vlies P; de Lange K; Bosse T; van Gool IC; Eggink FA; Wouters MCA; Komdeur FL; van der Slikke EC; Creutzberg CL; Kol A; Plat A; Glaire M; Church DN; Nijman HW; de Bruyn M
    Cancer Immunol Res; 2019 May; 7(5):784-796. PubMed ID: 30872264
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.
    Lee S; Yamauchi T; Kinoshita K; Imamura S; Kamiya K
    J Clin Exp Hematop; 2017 Oct; 57(2):64-68. PubMed ID: 28883219
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Incidence and Risk Assessment of Tumor Lysis Syndrome in Patients with Advanced Germ Cell cancer].
    Kurobe M; Kawai K; Tanaka K; Ichioka D; Yoshino T; Kandori S; Kawahara T; Waku N; Takaoka E; Kojima T; Joraku A; Suetomi T; Miyazaki J; Nishiyama H
    Hinyokika Kiyo; 2016 May; 62(5):237-42. PubMed ID: 27320114
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.